 PALO ALTO, Calif., Dec. 20, 2022 GLOBE NEWSWIRE 180 Life Sciences Corp. NASDAQ: ATNF, 180 Life Sciences or the Company, a clinical-stage biotechnology company, today announced that it has entered into a definitive agreement with a single healthcare-focused U.S. institutional investor, for the purchase and sale of 1,714,286 shares of the Companys common stock ... The post 180 Life Sciences Corp. Announces 6 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules ap... 